{"transactions":[{"id":737505,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T01:21:58.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":14504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2026."}],"balance_after":14504,"derivative":{"exercise_price":26.89,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":14504},"source":{"system":"sec-edgar","filing":"0001437749-26-020722","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774926020722/rdgdoc.xml","form_type":"4"}},{"id":737504,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T01:21:58.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on July 11, 2026."}],"balance_after":30000,"derivative":{"exercise_price":26.89,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-26-020722","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774926020722/rdgdoc.xml","form_type":"4"}},{"id":739292,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-12T18:35:11.000Z","date":"2026-06-12","kind":"purchase","planned":false,"acquired":true,"shares":3810000,"price":13.12,"value":49987200.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":573883879,"source":{"system":"sec-edgar","filing":"0001507650-26-000007","document":"wk-form4_1781289308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000150765026000007/wk-form4_1781289308.xml","form_type":"4"}},{"id":749283,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-04T21:45:03.000Z","date":"2026-06-04","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":14.6,"value":1460000.0,"ownership":{"direct":false,"nature":"By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":25824474,"source":{"system":"sec-edgar","filing":"0001507650-26-000005","document":"wk-form4_1780609499.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000150765026000005/wk-form4_1780609499.xml","form_type":"4"}},{"id":945842,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-07T00:52:54.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":11232,"price":8.76,"value":98392.32,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was issued to the reporting person's spouse pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $98,400."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person's spouse remaining as a non-salaried director on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or any other purpose."}],"balance_after":11232,"derivative":{"exercise_price":17.52,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":11232},"source":{"system":"sec-edgar","filing":"0001507650-26-000003","document":"wk-form4_1767747171.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000150765026000003/wk-form4_1767747171.xml","form_type":"4"}},{"id":1014148,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-23T20:06:32.000Z","date":"2025-10-21","kind":"grant","planned":false,"acquired":true,"shares":13980789,"price":18.74,"value":261999985.86,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of October 21, 2025, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person and certain other parties at a purchase price of $18.74 per share. The transaction is anticipated to close on or about October 23, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":570073879,"source":{"system":"sec-edgar","filing":"0001507650-25-000003","document":"wk-form4_1761249988.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000150765025000003/wk-form4_1761249988.xml","form_type":"4"}},{"id":1014147,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-23T20:06:32.000Z","date":"2025-10-21","kind":"purchase","planned":false,"acquired":true,"shares":26680,"price":18.74,"value":499983.2,"ownership":{"direct":false,"nature":"Immediate family member"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of October 21, 2025, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person and certain other parties at a purchase price of $18.74 per share. The transaction is anticipated to close on or about October 23, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":76680,"source":{"system":"sec-edgar","filing":"0001507650-25-000003","document":"wk-form4_1761249988.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000150765025000003/wk-form4_1761249988.xml","form_type":"4"}},{"id":1014146,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-23T20:06:32.000Z","date":"2025-10-21","kind":"grant","planned":false,"acquired":true,"shares":266808,"price":18.74,"value":4999981.92,"ownership":{"direct":false,"nature":"By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of October 21, 2025, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person and certain other parties at a purchase price of $18.74 per share. The transaction is anticipated to close on or about October 23, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":25724474,"source":{"system":"sec-edgar","filing":"0001507650-25-000003","document":"wk-form4_1761249988.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000150765025000003/wk-form4_1761249988.xml","form_type":"4"}},{"id":1042551,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-11T23:36:31.000Z","date":"2025-09-11","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":18.07,"value":90350.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose"}],"balance_after":556093090,"source":{"system":"sec-edgar","filing":"0001599298-25-000143","document":"wk-form4_1757633787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929825000143/wk-form4_1757633787.xml","form_type":"4"}},{"id":1042550,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-11T23:36:31.000Z","date":"2025-09-10","kind":"purchase","planned":false,"acquired":true,"shares":333394,"price":17.68,"value":5894405.92,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.49 to $17.89 per share, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose"}],"balance_after":556088090,"source":{"system":"sec-edgar","filing":"0001599298-25-000143","document":"wk-form4_1757633787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929825000143/wk-form4_1757633787.xml","form_type":"4"}},{"id":1061411,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-08-20T01:23:04.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":24134,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2025."}],"balance_after":24134,"derivative":{"exercise_price":16.16,"expiration_date":"2035-08-15","underlying":"Common Stock","underlying_shares":24134},"source":{"system":"sec-edgar","filing":"0001437749-25-027396","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774925027396/rdgdoc.xml","form_type":"4"}},{"id":1061410,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-08-20T01:23:04.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 15, 2025."}],"balance_after":30000,"derivative":{"exercise_price":16.16,"expiration_date":"2035-08-15","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-25-027396","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774925027396/rdgdoc.xml","form_type":"4"}},{"id":1127281,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-06-02T21:01:16.000Z","date":"2025-05-30","kind":"exercise","planned":false,"acquired":false,"shares":74545,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 30, 2025, the Reporting Person's spouse exercised an option to purchase 74,545 shares of the Issuer's common stock at an exercise price of $2.64 per share. The Reporting Person's spouse did not sell the underlying shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2024. The shares underlying the option vested in four equal quarterly installments on March 31, June 30, September 30 and December 31, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":2.64,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":74545},"source":{"system":"sec-edgar","filing":"0001599298-25-000107","document":"wk-form4_1748898068.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929825000107/wk-form4_1748898068.xml","form_type":"4"}},{"id":1127280,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-06-02T21:01:16.000Z","date":"2025-05-30","kind":"exercise","planned":false,"acquired":true,"shares":74545,"price":2.64,"value":196798.8,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 30, 2025, the Reporting Person's spouse exercised an option to purchase 74,545 shares of the Issuer's common stock at an exercise price of $2.64 per share. The Reporting Person's spouse did not sell the underlying shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":555754696,"source":{"system":"sec-edgar","filing":"0001599298-25-000107","document":"wk-form4_1748898068.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929825000107/wk-form4_1748898068.xml","form_type":"4"}},{"id":1162311,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-01T22:03:44.000Z","date":"2025-04-29","kind":"grant","planned":false,"acquired":true,"shares":9590558,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest as follows: (i) 50% of such shares vested as of April 29, 2025, and (ii) the remaining 50% of such shares vest in three equal annual installments, with the first such installment occurring on October 13, 2025."}],"balance_after":9590558,"derivative":{"exercise_price":1.68,"expiration_date":"2033-10-13","underlying":"Common Stock","underlying_shares":9590558},"source":{"system":"sec-edgar","filing":"0001599298-25-000091","document":"wk-form4_1746137015.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929825000091/wk-form4_1746137015.xml","form_type":"4"}},{"id":1162310,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-01T22:03:44.000Z","date":"2025-04-29","kind":"grant","planned":false,"acquired":true,"shares":400000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest as follows: (i) 50% of such shares vested as of April 29, 2025, and (ii) the remaining 50% of such shares vest in three equal annual installments, with the first such installment occurring on October 13, 2025."}],"balance_after":400000,"derivative":{"exercise_price":1.29,"expiration_date":"2032-09-09","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001599298-25-000091","document":"wk-form4_1746137015.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929825000091/wk-form4_1746137015.xml","form_type":"4"}},{"id":1162309,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-01T22:03:44.000Z","date":"2025-04-29","kind":"grant","planned":false,"acquired":true,"shares":1040000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest as follows: (i) 50% of such shares vested as of April 29, 2025, and (ii) the remaining 50% of such shares vest in three equal annual installments, with the first such installment occurring on October 13, 2025."}],"balance_after":1040000,"derivative":{"exercise_price":1.06,"expiration_date":"2032-06-28","underlying":"Common Stock","underlying_shares":1040000},"source":{"system":"sec-edgar","filing":"0001599298-25-000091","document":"wk-form4_1746137015.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929825000091/wk-form4_1746137015.xml","form_type":"4"}},{"id":1174580,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Warrant (right to buy)","published_at":"2025-04-09T21:19:31.000Z","date":"2025-04-08","kind":"other","planned":false,"acquired":true,"shares":3985055,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 8, 2025, the Reporting Person's spouse exercised warrants to purchase an aggregate of 3,985,055 shares of the Issuer's common stock at an exercise price of $1.58 per share"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":1.58,"exercise_date":"2020-06-24","expiration_date":"2029-12-24","underlying":"Common Stock","underlying_shares":3985055},"source":{"system":"sec-edgar","filing":"0001599298-25-000060","document":"wk-form4_1744233562.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929825000060/wk-form4_1744233562.xml","form_type":"4"}},{"id":1174579,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-09T21:19:31.000Z","date":"2025-04-08","kind":"other","planned":false,"acquired":true,"shares":3985055,"price":1.58,"value":6296386.9,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 8, 2025, the Reporting Person's spouse exercised warrants to purchase an aggregate of 3,985,055 shares of the Issuer's common stock at an exercise price of $1.58 per share"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":555680151,"source":{"system":"sec-edgar","filing":"0001599298-25-000060","document":"wk-form4_1744233562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929825000060/wk-form4_1744233562.xml","form_type":"4"}},{"id":1273541,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Warrant (right to buy)","published_at":"2025-02-11T23:20:57.000Z","date":"2025-02-03","kind":"other","planned":false,"acquired":false,"shares":30121,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":11,"exercise_date":"2024-07-03","expiration_date":"2029-07-03","underlying":"Common Stock","underlying_shares":30121},"source":{"system":"sec-edgar","filing":"0001437749-25-003449","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774925003449/rdgdoc.xml","form_type":"4"}},{"id":1273540,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Warrant (right to buy)","published_at":"2025-02-11T23:20:57.000Z","date":"2025-01-24","kind":"other","planned":false,"acquired":false,"shares":30121,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":11,"exercise_date":"2024-07-03","expiration_date":"2029-07-03","underlying":"Common Stock","underlying_shares":30121},"source":{"system":"sec-edgar","filing":"0001437749-25-003449","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774925003449/rdgdoc.xml","form_type":"4"}},{"id":1273539,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-02-11T23:20:57.000Z","date":"2025-02-03","kind":"other","planned":false,"acquired":true,"shares":30121,"price":11,"value":331331.0,"ownership":{"direct":true},"balance_after":725395,"source":{"system":"sec-edgar","filing":"0001437749-25-003449","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774925003449/rdgdoc.xml","form_type":"4"}},{"id":1273538,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-02-11T23:20:57.000Z","date":"2025-01-24","kind":"other","planned":false,"acquired":true,"shares":30121,"price":11,"value":331331.0,"ownership":{"direct":true},"balance_after":695274,"source":{"system":"sec-edgar","filing":"0001437749-25-003449","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774925003449/rdgdoc.xml","form_type":"4"}},{"id":1309853,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T00:39:43.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":10724,"price":9.18,"value":98446.32,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2025 to the Reporting Person's spouse. The shares underlying the option shall vest in four quarterly installments, subject to continued service on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":10724,"derivative":{"exercise_price":18.35,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":10724},"source":{"system":"sec-edgar","filing":"0001599298-25-000029","document":"wk-form4_1736210375.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929825000029/wk-form4_1736210375.xml","form_type":"4"}},{"id":1391569,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Warrant (right to buy)","published_at":"2024-10-03T20:54:29.000Z","date":"2024-10-03","kind":"other","planned":false,"acquired":false,"shares":315681,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Shaun Zanganeh Irrevocable Trust, with the Reporting Person as Trustee"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 3, 2024, the Shaun Zanganeh Irrevocable Trust exercised a warrant to purchase 315,681 shares of the Issuer's common stock at an exercise price of $1.58 per share."}],"balance_after":0,"derivative":{"exercise_price":1.58,"exercise_date":"2020-06-24","expiration_date":"2029-12-24","underlying":"Common Stock","underlying_shares":315681},"source":{"system":"sec-edgar","filing":"0001599298-24-000146","document":"wk-form4_1727988861.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929824000146/wk-form4_1727988861.xml","form_type":"4"}},{"id":1391568,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-10-03T20:54:29.000Z","date":"2024-10-03","kind":"other","planned":false,"acquired":true,"shares":315681,"price":1.58,"value":498775.98,"ownership":{"direct":false,"nature":"By the Shaun Zanganeh Irrevocable Trust, with the Reporting Person as Trustee"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 3, 2024, the Shaun Zanganeh Irrevocable Trust exercised a warrant to purchase 315,681 shares of the Issuer's common stock at an exercise price of $1.58 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":10199776,"source":{"system":"sec-edgar","filing":"0001599298-24-000146","document":"wk-form4_1727988861.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929824000146/wk-form4_1727988861.xml","form_type":"4"}},{"id":1407469,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-09-13T23:29:45.000Z","date":"2024-09-11","kind":"grant","planned":false,"acquired":true,"shares":44052,"price":22.7,"value":999980.4,"ownership":{"direct":false,"nature":"By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of September 11, 2024, pursuant to which the Issuer agreed to sell shares of common stock to the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee, at a purchase price of $22.70 per share. The transaction closed on September 13, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":24967852,"source":{"system":"sec-edgar","filing":"0001599298-24-000141","document":"wk-form4_1726270177.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929824000141/wk-form4_1726270177.xml","form_type":"4"}},{"id":1424047,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Option (right to buy)","published_at":"2024-08-23T20:42:26.000Z","date":"2024-08-23","kind":"grant","planned":false,"acquired":true,"shares":2397640,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These performance-based stock options vested on August 23, 2024, upon the attainment of the satisfaction of certain financial performance objectives. Note this does not include an additional 9,590,558 shares underlying options which were granted on October 13, 2023 that remain subject to the satisfaction of performance conditions."}],"balance_after":2397640,"derivative":{"exercise_price":1.68,"expiration_date":"2033-10-13","underlying":"Common Stock","underlying_shares":2397640},"source":{"system":"sec-edgar","filing":"0001599298-24-000123","document":"wk-form4_1724445740.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929824000123/wk-form4_1724445740.xml","form_type":"4"}},{"id":1424046,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Option (right to buy)","published_at":"2024-08-23T20:42:26.000Z","date":"2024-08-23","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These performance-based stock options vested on August 23, 2024, upon the attainment of the satisfaction of certain financial performance objectives. Note this does not include an additional 400,000 shares underlying options which were granted on September 9, 2022 that remain subject to the satisfaction of performance conditions."}],"balance_after":100000,"derivative":{"exercise_price":1.29,"expiration_date":"2032-09-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001599298-24-000123","document":"wk-form4_1724445740.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929824000123/wk-form4_1724445740.xml","form_type":"4"}},{"id":1424045,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Option (right to buy)","published_at":"2024-08-23T20:42:26.000Z","date":"2024-08-23","kind":"grant","planned":false,"acquired":true,"shares":260000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These performance-based stock options vested on August 23, 2024, upon the attainment of the satisfaction of certain financial performance objectives. Note this does not include an additional 1,040,000 shares underlying options which were granted on June 28, 2022, that remain subject to the satisfaction of performance conditions."}],"balance_after":260000,"derivative":{"exercise_price":1.06,"expiration_date":"2032-06-28","underlying":"Common Stock","underlying_shares":260000},"source":{"system":"sec-edgar","filing":"0001599298-24-000123","document":"wk-form4_1724445740.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929824000123/wk-form4_1724445740.xml","form_type":"4"}},{"id":1434531,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-08-13T22:50:46.000Z","date":"2024-08-09","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares subject to the option will vest on the date of the Issuer's next annual meeting of stockholders and the remaining shares will vest on a monthly basis over three years thereafter, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":200000,"derivative":{"exercise_price":15.65,"expiration_date":"2034-08-09","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001437749-24-026499","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774924026499/rdgdoc.xml","form_type":"4"}},{"id":1457358,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Warrant (right to buy)","published_at":"2024-07-09T13:20:42.000Z","date":"2024-07-03","kind":"purchase","planned":false,"acquired":true,"shares":30121,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."}],"balance_after":30121,"derivative":{"exercise_price":11,"exercise_date":"2024-07-03","expiration_date":"2029-07-03","underlying":"Common Stock","underlying_shares":30121},"source":{"system":"sec-edgar","filing":"0001437749-24-022360","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774924022360/rdgdoc.xml","form_type":"4"}},{"id":1457357,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Warrant (right to buy)","published_at":"2024-07-09T13:20:42.000Z","date":"2024-07-03","kind":"purchase","planned":false,"acquired":true,"shares":30121,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."}],"balance_after":30121,"derivative":{"exercise_price":11,"exercise_date":"2024-07-03","expiration_date":"2029-07-03","underlying":"Common Stock","underlying_shares":30121},"source":{"system":"sec-edgar","filing":"0001437749-24-022360","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774924022360/rdgdoc.xml","form_type":"4"}},{"id":1457356,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-07-09T13:20:42.000Z","date":"2024-07-03","kind":"other","planned":false,"acquired":true,"shares":60242,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."}],"balance_after":665153,"source":{"system":"sec-edgar","filing":"0001437749-24-022360","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774924022360/rdgdoc.xml","form_type":"4"}},{"id":1470409,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-06-24T23:40:32.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":8247,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2024."}],"balance_after":8247,"derivative":{"exercise_price":14.55,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":8247},"source":{"system":"sec-edgar","filing":"0001437749-24-021131","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774924021131/rdgdoc.xml","form_type":"4"}},{"id":1470408,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-06-24T23:40:32.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on July 6, 2024."}],"balance_after":20000,"derivative":{"exercise_price":14.55,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-24-021131","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774924021131/rdgdoc.xml","form_type":"4"}},{"id":1559278,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-28T00:28:30.000Z","date":"2024-03-27","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":3.71,"value":74200.0,"ownership":{"direct":false,"nature":"Immediate family member"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.68 to $3.75 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001599298-24-000047","document":"wk-form4_1711585700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929824000047/wk-form4_1711585700.xml","form_type":"4"}},{"id":1559277,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-28T00:28:30.000Z","date":"2024-03-26","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":3.75,"value":112500.0,"ownership":{"direct":false,"nature":"Immediate family member"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.73 to $3.78 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001599298-24-000047","document":"wk-form4_1711585700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929824000047/wk-form4_1711585700.xml","form_type":"4"}},{"id":1559276,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-28T00:28:30.000Z","date":"2024-03-27","kind":"purchase","planned":false,"acquired":true,"shares":34321,"price":3.72,"value":127674.12,"ownership":{"direct":false,"nature":"By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.69 to $3.72 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":24923800,"source":{"system":"sec-edgar","filing":"0001599298-24-000047","document":"wk-form4_1711585700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929824000047/wk-form4_1711585700.xml","form_type":"4"}},{"id":1559275,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-28T00:28:30.000Z","date":"2024-03-27","kind":"purchase","planned":false,"acquired":true,"shares":26000,"price":3.72,"value":96720.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.70 to $3.73 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":520814,"source":{"system":"sec-edgar","filing":"0001599298-24-000047","document":"wk-form4_1711585700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929824000047/wk-form4_1711585700.xml","form_type":"4"}},{"id":1712186,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant (right to buy)","published_at":"2023-12-13T22:11:56.000Z","date":"2023-12-11","kind":"other","planned":false,"acquired":false,"shares":315681,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person exercised certain warrants to purchase shares of common stock in accordance with the terms of such warrants."}],"balance_after":0,"derivative":{"exercise_price":1.58,"exercise_date":"2023-12-11","expiration_date":"2029-12-24","underlying":"Common Stock","underlying_shares":315681},"source":{"system":"sec-edgar","filing":"0001599298-23-000103","document":"wk-form4_1702505507.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929823000103/wk-form4_1702505507.xml","form_type":"4"}},{"id":1712185,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant (right to buy)","published_at":"2023-12-13T22:11:56.000Z","date":"2023-12-11","kind":"other","planned":false,"acquired":false,"shares":489814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person exercised certain warrants to purchase shares of common stock in accordance with the terms of such warrants."}],"balance_after":0,"derivative":{"exercise_price":1.44,"exercise_date":"2023-12-11","expiration_date":"2025-06-30","underlying":"Common Stock","underlying_shares":489814},"source":{"system":"sec-edgar","filing":"0001599298-23-000103","document":"wk-form4_1702505507.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929823000103/wk-form4_1702505507.xml","form_type":"4"}},{"id":1712184,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-12-13T22:11:56.000Z","date":"2023-12-11","kind":"other","planned":false,"acquired":true,"shares":315681,"price":1.58,"value":498775.98,"ownership":{"direct":false,"nature":"By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person exercised certain warrants to purchase shares of common stock in accordance with the terms of such warrants."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":24889479,"source":{"system":"sec-edgar","filing":"0001599298-23-000103","document":"wk-form4_1702505507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929823000103/wk-form4_1702505507.xml","form_type":"4"}},{"id":1712183,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-12-13T22:11:56.000Z","date":"2023-12-12","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":2.07,"value":10350.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person purchased these shares in a single transaction on the open market."}],"balance_after":494814,"source":{"system":"sec-edgar","filing":"0001599298-23-000103","document":"wk-form4_1702505507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929823000103/wk-form4_1702505507.xml","form_type":"4"}},{"id":1712182,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-12-13T22:11:56.000Z","date":"2023-12-11","kind":"other","planned":false,"acquired":true,"shares":489814,"price":1.44,"value":705332.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person exercised certain warrants to purchase shares of common stock in accordance with the terms of such warrants."}],"balance_after":489814,"source":{"system":"sec-edgar","filing":"0001599298-23-000103","document":"wk-form4_1702505507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929823000103/wk-form4_1702505507.xml","form_type":"4"}},{"id":1740448,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-11-15T22:37:07.000Z","date":"2023-11-13","kind":"exercise","planned":false,"acquired":false,"shares":56075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Company's Amended and Restated Outside Director Compensation Policy, this option vested on a quartetrly basis following the Company's 2022 Annual Stockholder Meeting."}],"balance_after":0,"derivative":{"exercise_price":2.14,"expiration_date":"2032-05-19","underlying":"Common Stock","underlying_shares":56075},"source":{"system":"sec-edgar","filing":"0001437749-23-032198","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774923032198/rdgdoc.xml","form_type":"4"}},{"id":1740447,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-11-15T22:37:07.000Z","date":"2023-11-13","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Company's Amended and Restated Outside Director Compensation Policy, this option vested on a monthly basis following the Company's 2022 Annual Stockholder Meeting."}],"balance_after":0,"derivative":{"exercise_price":2.14,"expiration_date":"2032-05-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-23-032198","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774923032198/rdgdoc.xml","form_type":"4"}},{"id":1740446,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-11-15T22:37:07.000Z","date":"2023-11-13","kind":"exercise","planned":false,"acquired":true,"shares":56075,"price":2.14,"value":120000.5,"ownership":{"direct":true},"balance_after":604911,"source":{"system":"sec-edgar","filing":"0001437749-23-032198","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774923032198/rdgdoc.xml","form_type":"4"}},{"id":1740445,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-11-15T22:37:07.000Z","date":"2023-11-13","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":2.14,"value":42800.0,"ownership":{"direct":true},"balance_after":548836,"source":{"system":"sec-edgar","filing":"0001437749-23-032198","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774923032198/rdgdoc.xml","form_type":"4"}},{"id":1759693,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-10-16T20:08:25.000Z","date":"2023-10-13","kind":"grant","planned":false,"acquired":true,"shares":11988198,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on October 13, 2023. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on October 13, 2024. Note this does not include an additional 11,988,198 options which were granted on October 13, 2023 and are subject to the satisfaction of performance conditions based on market capitalization and revenue targets."}],"balance_after":11988198,"derivative":{"exercise_price":1.68,"expiration_date":"2033-10-13","underlying":"Common Stock","underlying_shares":11988198},"source":{"system":"sec-edgar","filing":"0001599298-23-000090","document":"wk-form4_1697486896.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929823000090/wk-form4_1697486896.xml","form_type":"4"}},{"id":1833548,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Warrant (right to buy)","published_at":"2023-07-07T00:30:05.000Z","date":"2023-06-09","kind":"other","planned":false,"acquired":false,"shares":86668,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.05,"exercise_date":"2022-06-09","expiration_date":"2027-06-09","underlying":"Common Stock","underlying_shares":86668},"source":{"system":"sec-edgar","filing":"0001437749-23-019535","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774923019535/rdgdoc.xml","form_type":"4/A","original_submission_date":"2023-06-13"}},{"id":1833547,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-07-07T00:30:05.000Z","date":"2023-06-09","kind":"other","planned":false,"acquired":true,"shares":86668,"price":2.05,"value":177669.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of shares beneficially owned, as reported on the Form 4 filed on June 13, 2023, erroneously included options held by the Reporting Person."}],"balance_after":528836,"source":{"system":"sec-edgar","filing":"0001437749-23-019535","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774923019535/rdgdoc.xml","form_type":"4/A","original_submission_date":"2023-06-13"}},{"id":1856932,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Warrant (right to buy)","published_at":"2023-06-13T21:26:51.000Z","date":"2023-06-09","kind":"other","planned":false,"acquired":false,"shares":86668,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.05,"exercise_date":"2022-06-09","expiration_date":"2027-06-09","underlying":"Common Stock","underlying_shares":86668},"source":{"system":"sec-edgar","filing":"0001437749-23-017297","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774923017297/rdgdoc.xml","form_type":"4"}},{"id":1856931,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-13T21:26:51.000Z","date":"2023-06-09","kind":"other","planned":false,"acquired":true,"shares":86668,"price":2.05,"value":177669.4,"ownership":{"direct":true},"balance_after":791915,"source":{"system":"sec-edgar","filing":"0001437749-23-017297","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774923017297/rdgdoc.xml","form_type":"4"}},{"id":1864907,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-06-06T23:28:24.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":20168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2023."}],"balance_after":20168,"derivative":{"exercise_price":5.95,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":20168},"source":{"system":"sec-edgar","filing":"0001437749-23-016803","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774923016803/rdgdoc.xml","form_type":"4"}},{"id":1864906,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-06-06T23:28:24.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on June 25, 2023."}],"balance_after":20000,"derivative":{"exercise_price":5.95,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-23-016803","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000143774923016803/rdgdoc.xml","form_type":"4"}},{"id":1956415,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-CEO & President"}}],"security":"Common Stock","published_at":"2023-03-13T22:27:25.000Z","date":"2023-03-08","kind":"purchase","acquired":true,"shares":6748629,"price":1.05,"value":7086060.45,"ownership":{"direct":false,"nature":"By the Shaun Zanganeh Irrevocable Trust, with the Reporting Person as Trustee."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":9884095,"source":{"system":"sec-edgar","filing":"0001387131-23-003381","document":"zangeneh-form4a_030823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000138713123003381/zangeneh-form4a_030823.xml","form_type":"4/A","original_submission_date":"2023-03-08"}},{"id":1956414,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-CEO & President"}}],"security":"Common Stock","published_at":"2023-03-13T22:27:25.000Z","date":"2023-03-08","kind":"purchase","acquired":true,"shares":16778415,"price":1.05,"value":17617335.75,"ownership":{"direct":false,"nature":"By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes the number of shares of Common Stock that were inadvertently previously disclosed as being held by Dr. Zanganeh personally, which are held by the Mahkam Zanganeh Revocable Trust. Dr. Zanganeh does not directly hold any shares personally, all of her shares are held through the Mahkam Zanganeh Revocable Trust."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":24573798,"source":{"system":"sec-edgar","filing":"0001387131-23-003381","document":"zangeneh-form4a_030823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000138713123003381/zangeneh-form4a_030823.xml","form_type":"4/A","original_submission_date":"2023-03-08"}},{"id":1962707,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-09T02:31:10.000Z","date":"2023-03-08","kind":"purchase","acquired":true,"shares":6748629,"price":1.05,"value":7086060.45,"ownership":{"direct":false,"nature":"By the Shaun Zanganeh Irrevocable Trust, with the Reporting Person as Trustee."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":9884095,"source":{"system":"sec-edgar","filing":"0001599298-23-000028","document":"wf-form4_167832905731524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929823000028/wf-form4_167832905731524.xml","form_type":"4"}},{"id":1962706,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-09T02:31:10.000Z","date":"2023-03-08","kind":"purchase","acquired":true,"shares":804672,"price":1.05,"value":844905.6,"ownership":{"direct":false,"nature":"By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":1178529,"source":{"system":"sec-edgar","filing":"0001599298-23-000028","document":"wf-form4_167832905731524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929823000028/wf-form4_167832905731524.xml","form_type":"4"}},{"id":1962705,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-09T02:31:10.000Z","date":"2023-03-08","kind":"purchase","acquired":true,"shares":15973743,"price":1.05,"value":16772430.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering."}],"balance_after":23395269,"source":{"system":"sec-edgar","filing":"0001599298-23-000028","document":"wf-form4_167832905731524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929823000028/wf-form4_167832905731524.xml","form_type":"4"}},{"id":2090841,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-CEO & President"}}],"security":"Common Stock","published_at":"2022-12-09T23:22:47.000Z","date":"2022-12-06","kind":"other","acquired":true,"shares":373857,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"373,857 shares of Common Stock were issued to the Reporting Person as payment of interest in connection with a Note Purchase Agreement, dated December 6, 2022, by and among the Issuer, the Reporting Person and Robert W. Duggan. The determination of the number of shares of Common Stock to be issued to the Reporting Person was based on a per share price of $0.79."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"373,857 shares of Common Stock were issued to the Reporting Person as payment of interest in connection with a Note Purchase Agreement, dated December 6, 2022, by and among the Issuer, the Reporting Person and Robert W. Duggan. The determination of the number of shares of Common Stock to be issued to the Reporting Person was based on a per share price of $0.79."}],"balance_after":10930849,"source":{"system":"sec-edgar","filing":"0001387131-22-012291","document":"zangeneh-form4_120622.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000138713122012291/zangeneh-form4_120622.xml","form_type":"4"}},{"id":2179171,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-CEO & President"}}],"security":"Common Stock","published_at":"2022-08-18T20:36:42.000Z","date":"2022-08-16","kind":"purchase","acquired":true,"shares":1030925,"price":0.97,"value":999997.25,"ownership":{"direct":false,"nature":"By the Shaun Zanganeh Irrevocable Trust, with the Reporting Person as Trustee."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":3135466,"source":{"system":"sec-edgar","filing":"0001387131-22-008886","document":"zangeneh-form4_081622.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000138713122008886/zangeneh-form4_081622.xml","form_type":"4"}},{"id":2179170,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-CEO & President"}}],"security":"Common Stock","published_at":"2022-08-18T20:36:42.000Z","date":"2022-08-16","kind":"purchase","acquired":true,"shares":4593777,"price":0.97,"value":4455963.69,"ownership":{"direct":false,"nature":"By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":7061557,"source":{"system":"sec-edgar","filing":"0001387131-22-008886","document":"zangeneh-form4_081622.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000138713122008886/zangeneh-form4_081622.xml","form_type":"4"}},{"id":2179169,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-CEO & President"}}],"security":"Common Stock","published_at":"2022-08-18T20:36:42.000Z","date":"2022-08-16","kind":"purchase","acquired":true,"shares":184430,"price":0.97,"value":178897.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering."}],"balance_after":359969,"source":{"system":"sec-edgar","filing":"0001387131-22-008886","document":"zangeneh-form4_081622.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000138713122008886/zangeneh-form4_081622.xml","form_type":"4"}},{"id":2235497,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2022-06-10T22:59:54.000Z","date":"2022-06-09","kind":"purchase","acquired":true,"shares":86668,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $2.05 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $2.05."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC."}],"balance_after":86668,"derivative":{"exercise_price":2.05,"exercise_date":"2022-06-09","expiration_date":"2027-06-09","underlying":"Common Stock","underlying_shares":86668},"source":{"system":"sec-edgar","filing":"0001387131-22-006923","document":"zangeneh-form4_060922.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000138713122006923/zangeneh-form4_060922.xml","form_type":"4"}},{"id":2235496,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-10T22:59:54.000Z","date":"2022-06-09","kind":"other","acquired":true,"shares":86668,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $2.05 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $2.05."}],"balance_after":442168,"source":{"system":"sec-edgar","filing":"0001387131-22-006923","document":"zangeneh-form4_060922.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000138713122006923/zangeneh-form4_060922.xml","form_type":"4"}},{"id":2259558,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-24T00:52:13.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":56075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on August 19, 2022."}],"balance_after":56075,"derivative":{"exercise_price":2.14,"expiration_date":"2032-05-19","underlying":"Common Stock","underlying_shares":56075},"source":{"system":"sec-edgar","filing":"0001104659-22-064002","document":"tm2216672-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000110465922064002/tm2216672-2_4seq1.xml","form_type":"4"}},{"id":2259557,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-24T00:52:13.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on June 19, 2022."}],"balance_after":20000,"derivative":{"exercise_price":2.14,"expiration_date":"2032-05-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-22-064002","document":"tm2216672-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000110465922064002/tm2216672-2_4seq1.xml","form_type":"4"}},{"id":2465399,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-17T21:16:45.000Z","date":"2021-12-15","kind":"grant","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(2) Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"(1) The option was granted on December 15, 2021. The shares underlying the option are scheduled to vest on December 15, 2024 (the three-year anniversary of the grant date)."}],"balance_after":15000,"derivative":{"exercise_price":4.75,"expiration_date":"2031-12-15","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001599298-21-000039","document":"wf-form4_163977578709580.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929821000039/wf-form4_163977578709580.xml","form_type":"4"}},{"id":2700429,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-21T21:09:15.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":8026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one year period, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":8026,"derivative":{"exercise_price":18.69,"exercise_date":"2021-09-05","expiration_date":"2031-05-20","underlying":"Common Stock","underlying_shares":8026},"source":{"system":"sec-edgar","filing":"0001209191-21-035015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000120919121035015/doc4.xml","form_type":"4"}},{"id":2700428,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-21T21:09:15.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":20000,"derivative":{"exercise_price":18.69,"exercise_date":"2021-06-20","expiration_date":"2031-05-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-035015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000120919121035015/doc4.xml","form_type":"4"}},{"id":2711950,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-05-14T20:37:02.000Z","date":"2021-05-12","kind":"purchase","acquired":true,"shares":389077,"price":5.24,"value":2038763.48,"ownership":{"direct":false,"nature":"By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering."}],"balance_after":2643319,"source":{"system":"sec-edgar","filing":"0000921895-21-001334","document":"form412566zan_05142021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000092189521001334/form412566zan_05142021.xml","form_type":"4"}},{"id":2900394,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2021-01-21T21:32:32.000Z","date":"2021-01-19","kind":"other","acquired":false,"shares":307,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Immediate Family Member 1"},"balance_after":0,"derivative":{"exercise_price":7.01,"exercise_date":"2020-06-15","expiration_date":"2025-06-15","underlying":"Common Stock","underlying_shares":307},"source":{"system":"sec-edgar","filing":"0001209191-21-004669","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000120919121004669/doc4.xml","form_type":"4"}},{"id":2900393,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2021-01-21T21:32:32.000Z","date":"2021-01-08","kind":"other","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":7.01,"exercise_date":"2020-06-15","expiration_date":"2025-06-15","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001209191-21-004669","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000120919121004669/doc4.xml","form_type":"4"}},{"id":2900392,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-21T21:32:32.000Z","date":"2021-01-19","kind":"other","acquired":true,"shares":307,"price":7.01,"value":2152.07,"ownership":{"direct":false,"nature":"Immediate Family Member 1"},"balance_after":107074,"source":{"system":"sec-edgar","filing":"0001209191-21-004669","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000120919121004669/doc4.xml","form_type":"4"}},{"id":2900391,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-21T21:32:32.000Z","date":"2021-01-08","kind":"other","acquired":true,"shares":3000,"price":7.01,"value":21030.0,"ownership":{"direct":true},"balance_after":355500,"source":{"system":"sec-edgar","filing":"0001209191-21-004669","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000120919121004669/doc4.xml","form_type":"4"}},{"id":2967555,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-24T23:12:11.000Z","date":"2020-11-22","kind":"grant","acquired":true,"shares":2400000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted on November 22, 2020 pursuant to the Issuer's Stock Incentive Plan. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on November 22, 2021, subject to the satisfaction of certain performance targets."}],"balance_after":3724499,"derivative":{"exercise_price":4.4,"exercise_date":"2021-11-22","expiration_date":"2030-11-22","underlying":"Common Stock","underlying_shares":2400000},"source":{"system":"sec-edgar","filing":"0000921895-20-003108","document":"form412566zan_11242020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000092189520003108/form412566zan_11242020.xml","form_type":"4"}},{"id":2980721,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T22:25:41.000Z","date":"2020-11-11","kind":"grant","acquired":true,"shares":3323,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted on November 11, 2020 pursuant to the Issuer's Stock Incentive Plan. The shares underlying the option are scheduled to vest in full on December 31, 2020."}],"balance_after":1324500,"derivative":{"exercise_price":3.71,"exercise_date":"2020-12-31","expiration_date":"2030-11-11","underlying":"Common Stock","underlying_shares":3323},"source":{"system":"sec-edgar","filing":"0000921895-20-002948","document":"form412566001_11132020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000092189520002948/form412566001_11132020.xml","form_type":"4"}},{"id":2980720,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T22:25:41.000Z","date":"2020-11-11","kind":"grant","acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted on November 11, 2020 pursuant to the Issuer's Stock Incentive Plan. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on November 11, 2021."}],"balance_after":1321177,"derivative":{"exercise_price":3.71,"exercise_date":"2021-11-11","expiration_date":"2030-11-11","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000921895-20-002948","document":"form412566001_11132020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000092189520002948/form412566001_11132020.xml","form_type":"4"}},{"id":3099578,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-25T21:12:02.000Z","date":"2020-06-23","kind":"purchase","acquired":true,"shares":1193,"price":10.7017,"value":12767.1281,"ownership":{"direct":false,"nature":"Immediate Family Member 1"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's immediate family member received the shares from a banking institution as resolution to an error made by the institution in connection with a subscription order placed for the Issuer's rights offering. Such shares were not acquired directly from the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This is the weighted average purchase price of the shares, which ranged from $10.69 to $10.73 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4."}],"balance_after":106767,"source":{"system":"sec-edgar","filing":"0001209191-20-038948","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000120919120038948/doc4.xml","form_type":"4"}},{"id":3104028,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-19T20:22:58.000Z","date":"2020-06-17","kind":"purchase","acquired":true,"shares":7950,"price":7.01,"value":55729.5,"ownership":{"direct":false,"nature":"Immediate Family Member 1"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's immediate family member acquired the shares from a banking institution due to an error by such institution in connection with subscriptions for the Issuer's rights offering.  Such shares were not acquired from the Issuer."}],"balance_after":105574,"source":{"system":"sec-edgar","filing":"0001209191-20-037928","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000120919120037928/doc4.xml","form_type":"4"}},{"id":3106464,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2020-06-17T20:09:15.000Z","date":"2020-06-15","kind":"purchase","acquired":true,"shares":307,"ownership":{"direct":false,"nature":"Immediate Family Member 1"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares and warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering, as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired the shares and warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering, as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."}],"balance_after":307,"derivative":{"exercise_price":7.01,"exercise_date":"2020-06-15","expiration_date":"2025-06-15","underlying":"Common Stock","underlying_shares":307},"source":{"system":"sec-edgar","filing":"0001209191-20-037234","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000120919120037234/doc4.xml","form_type":"4"}},{"id":3106463,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2020-06-17T20:09:15.000Z","date":"2020-06-15","kind":"purchase","acquired":true,"shares":3000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares and warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering, as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired the shares and warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering, as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."}],"balance_after":3000,"derivative":{"exercise_price":7.01,"exercise_date":"2020-06-15","expiration_date":"2025-06-15","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001209191-20-037234","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000120919120037234/doc4.xml","form_type":"4"}},{"id":3106462,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-17T20:09:15.000Z","date":"2020-06-15","kind":"other","acquired":true,"shares":2050,"price":7.01,"value":14370.5,"ownership":{"direct":false,"nature":"Immediate Family Member 1"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares and warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering, as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."}],"balance_after":97624,"source":{"system":"sec-edgar","filing":"0001209191-20-037234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000120919120037234/doc4.xml","form_type":"4"}},{"id":3106461,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-17T20:09:15.000Z","date":"2020-06-15","kind":"other","acquired":true,"shares":20000,"price":7.01,"value":140200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares and warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering, as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."}],"balance_after":352500,"source":{"system":"sec-edgar","filing":"0001209191-20-037234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000120919120037234/doc4.xml","form_type":"4"}},{"id":3142178,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-19T22:26:45.000Z","date":"2020-05-18","kind":"grant","acquired":true,"shares":14071,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one year period, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":14071,"derivative":{"exercise_price":10.66,"exercise_date":"2020-09-05","expiration_date":"2030-05-18","underlying":"Common Stock","underlying_shares":14071},"source":{"system":"sec-edgar","filing":"0001209191-20-030682","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000120919120030682/doc4.xml","form_type":"4"}},{"id":3142177,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-19T22:26:45.000Z","date":"2020-05-18","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":20000,"derivative":{"exercise_price":10.66,"exercise_date":"2020-06-18","expiration_date":"2030-05-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-030682","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000120919120030682/doc4.xml","form_type":"4"}},{"id":3520234,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-17T20:18:20.000Z","date":"2019-05-16","kind":"grant","acquired":true,"shares":9210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one year period, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":9210,"derivative":{"exercise_price":13.03,"exercise_date":"2019-09-05","expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":9210},"source":{"system":"sec-edgar","filing":"0001209191-19-030902","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000120919119030902/doc4.xml","form_type":"4"}},{"id":3520233,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-17T20:18:20.000Z","date":"2019-05-16","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":15000,"derivative":{"exercise_price":13.03,"exercise_date":"2019-06-16","expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-030902","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000120919119030902/doc4.xml","form_type":"4"}},{"id":3698841,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-01-09T21:16:59.000Z","date":"2019-01-07","kind":"grant","acquired":true,"shares":2364,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will fully vest on the date of the Issuer's Annual Meeting to be held in 2019, subject to the Reporting Person's continued service through such vesting date."}],"balance_after":2364,"derivative":{"exercise_price":13.22,"expiration_date":"2029-01-07","underlying":"Common Stock","underlying_shares":2364},"source":{"system":"sec-edgar","filing":"0001209191-19-003042","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000120919119003042/doc4.xml","form_type":"4"}},{"id":3918241,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-24T22:41:27.000Z","date":"2018-05-23","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":15000,"derivative":{"exercise_price":15.27,"exercise_date":"2018-06-23","expiration_date":"2028-05-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-18-033158","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000120919118033158/doc4.xml","form_type":"4"}},{"id":3980697,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-28T19:51:08.000Z","date":"2017-03-20","kind":"purchase","acquired":true,"shares":1000,"price":22.38,"value":22380.0,"ownership":{"direct":false,"nature":"Immediate Family Member 2"},"balance_after":14000,"source":{"system":"sec-edgar","filing":"0001209191-18-021891","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000120919118021891/doc5.xml","form_type":"5"}},{"id":3980696,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-28T19:51:08.000Z","date":"2017-02-15","kind":"purchase","acquired":true,"shares":6200,"price":12.152,"value":75342.4,"ownership":{"direct":false,"nature":"Immediate Family Member 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This is the weighted average purchase price of the shares, which ranged from $12.10 to $12.199 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4."}],"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001209191-18-021891","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000120919118021891/doc5.xml","form_type":"5"}},{"id":3980695,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-28T19:51:08.000Z","date":"2017-02-13","kind":"purchase","acquired":true,"shares":1000,"price":10.966,"value":10966.0,"ownership":{"direct":false,"nature":"Immediate Family Member 2"},"balance_after":6800,"source":{"system":"sec-edgar","filing":"0001209191-18-021891","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000120919118021891/doc5.xml","form_type":"5"}},{"id":3980694,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-28T19:51:08.000Z","date":"2017-03-20","kind":"purchase","acquired":true,"shares":2000,"price":22.37,"value":44740.0,"ownership":{"direct":false,"nature":"Immediate Family Member 1"},"balance_after":27000,"source":{"system":"sec-edgar","filing":"0001209191-18-021891","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000120919118021891/doc5.xml","form_type":"5"}},{"id":3980693,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-28T19:51:08.000Z","date":"2017-03-17","kind":"purchase","acquired":true,"shares":2000,"price":23.93,"value":47860.0,"ownership":{"direct":false,"nature":"Immediate Family Member 1"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This is the weighted average purchase price of the shares, which ranged from $23.70 to $24.16 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001209191-18-021891","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000120919118021891/doc5.xml","form_type":"5"}},{"id":3980692,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-28T19:51:08.000Z","date":"2017-02-14","kind":"purchase","acquired":true,"shares":9500,"price":12.119,"value":115130.5,"ownership":{"direct":false,"nature":"Immediate Family Member 1"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This is the weighted average purchase price of the shares, which ranged from $12.00 to $12.499 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4."}],"balance_after":23000,"source":{"system":"sec-edgar","filing":"0001209191-18-021891","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000120919118021891/doc5.xml","form_type":"5"}},{"id":3980691,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-28T19:51:08.000Z","date":"2017-02-13","kind":"purchase","acquired":true,"shares":2000,"price":11.25,"value":22500.0,"ownership":{"direct":false,"nature":"Immediate Family Member 1"},"balance_after":13500,"source":{"system":"sec-edgar","filing":"0001209191-18-021891","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000120919118021891/doc5.xml","form_type":"5"}},{"id":4129996,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Maky","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-15T21:19:50.000Z","date":"2017-12-13","kind":"purchase","acquired":true,"shares":1100,"price":23.98,"value":26378.0,"ownership":{"direct":false,"nature":"Dependent Minor"},"balance_after":95574,"source":{"system":"sec-edgar","filing":"0001209191-17-065914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000120919117065914/doc4.xml","form_type":"4"}}],"next_cursor":"2017-12-15T21:19:50.000000Z,4129996"}